Personalized management of pheochromocytoma and paraganglioma
S Nölting, N Bechmann, D Taieb… - Endocrine …, 2022 - academic.oup.com
Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …
that allows their assignment to clusters based on underlying genetic alterations. With around …
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working …
JWM Lenders, MN Kerstens, L Amar… - Journal of …, 2020 - journals.lww.com
Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require
timely diagnosis because of their potentially serious cardiovascular and sometimes life …
timely diagnosis because of their potentially serious cardiovascular and sometimes life …
European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …
New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification
A molecular biology–based taxonomy has been proposed for pheochromocytoma and
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas
R García-Carbonero, F Matute Teresa… - Clinical and …, 2021 - Springer
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
S Nölting, M Ullrich, J Pietzsch, CG Ziegler… - Cancers, 2019 - mdpi.com
Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT
Y Sanli, I Garg, A Kandathil, T Kendi… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …
Performance of 68Ga-DOTA–conjugated somatostatin receptor–targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review …
We performed a systematic review and metaanalysis of the performance of 68Ga-DOTA–
conjugated somatostatin receptor–targeting peptide (68Ga-DOTA-SST) PET in the detection …
conjugated somatostatin receptor–targeting peptide (68Ga-DOTA-SST) PET in the detection …
Imaging of pheochromocytoma and paraganglioma
JA Carrasquillo, CC Chen, A Jha, A Ling… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Imaging plays a critical role in the management of pheochromocytomas and
paragangliomas and often guides treatment. The discovery of susceptibility genes …
paragangliomas and often guides treatment. The discovery of susceptibility genes …